Edesa Biotech Reports Fiscal Year 2024 Results
13 déc. 2024 16h30 HE
|
Edesa Biotech, Inc.
TORONTO, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
Edesa Biotech’s Founder Makes Strategic Investment in the Company
31 oct. 2024 08h15 HE
|
Edesa Biotech, Inc.
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
Edesa Biotech Announces Upcoming Conference Schedule
21 oct. 2024 08h15 HE
|
Edesa Biotech, Inc.
Edesa Biotech Announces Upcoming Conference Schedule
Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results
09 août 2024 16h20 HE
|
Edesa Biotech, Inc.
TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...